VisionCare Specialist Eye Hospital — Services & Clinical Model
The service lines and their indicative economics, the clinical service descriptions, the quality, outcomes and accreditation framework, and the patient journey.
Section 5 · Business Plan
Services & Clinical Model
The service lines and their indicative economics, the clinical service descriptions, the quality, outcomes and accreditation framework, and the patient journey.
VisionCare will deliver a comprehensive portfolio of ophthalmic
services structured around eight revenue-generating lines. The case mix
deliberately blends high-volume, reimbursable medical-surgical work
(which provides a resilient revenue base) with higher-margin elective
and premium procedures (which enhance profitability).
5.1 Service Lines & Indicative Economics
| Service Line | Capacity (cases/yr) | Avg. Net Price | Direct Cost % |
|---|---|---|---|
| Cataract surgery (phaco + IOL) | 3 000 | R22 500 | 34% |
| Refractive surgery (LASIK/PRK/SMILE) | 900 | R28 000 | 30% |
| Glaucoma procedures | 600 | R19 000 | 33% |
| Vitreoretinal surgery | 480 | R41 000 | 38% |
| Intravitreal injections (anti-VEGF) | 4 200 | R6 800 | 55% |
| Oculoplastic / adnexal surgery | 360 | R24 000 | 32% |
| Comprehensive consults & diagnostics | 18 000 | R1 450 | 18% |
| Optical & dispensing (retail) | 9 000 | R2 600 | 52% |
Table 5.1 — Service lines, full-capacity volumes and indicative
unit economics (Year 1 prices)
5.2 Clinical Service Descriptions
Cataract surgery. The cornerstone of the hospital.
High-volume phacoemulsification with monofocal, toric and premium
multifocal intraocular lens options. Standardised lists maximise theatre
efficiency and underpin the most predictable, scheme-funded revenue
stream.
Refractive surgery. LASIK, PRK and SMILE procedures
delivered in a dedicated laser suite. Predominantly elective and
cash-funded, this line carries strong margins and supports premium brand
positioning.
Glaucoma services. Medical, laser (SLT) and surgical
management including trabeculectomy and minimally-invasive glaucoma
surgery (MIGS), supported by visual-field and OCT monitoring for this
chronic, lifelong patient cohort.
Vitreoretinal surgery. Complex posterior-segment
surgery for retinal detachment, diabetic complications and macular
disease — a high-acuity, high-value service that few competitors offer
at scale.
Intravitreal therapy (anti-VEGF). Recurring
injection therapy for diabetic macular oedema, age-related macular
degeneration and retinal vein occlusion. High repeat-visit frequency
creates an annuity-like revenue stream that grows with the diabetic
population.
Oculoplastics, diagnostics, optometry & optical.
Adnexal and lid surgery, comprehensive consultations, advanced imaging,
and an on-site optical laboratory and dispensary that captures
downstream refractive-correction revenue.
5.3 Quality, Outcomes & Accreditation
Clinical governance will be built around continuous outcomes
measurement — visual-acuity gain, complication and re-operation rates,
endophthalmitis surveillance and patient-reported outcomes — benchmarked
against international registries. The hospital will pursue and maintain
OHSC accreditation, infection-prevention certification for its CSSD, and
full compliance with HPCSA and SAHPRA requirements. A standing
morbidity-and-mortality and clinical-audit cycle will drive measurable,
transparent quality.
| Clinical Outcome Metric | International Benchmark | VisionCare Target |
|---|---|---|
| Cataract: posterior capsule rupture rate | <2% | <1.5% |
| Cataract: endophthalmitis rate | <0.1% | <0.05% |
| Cataract: visual-acuity improvement | >90% | >95% |
| Refractive: within ±0.50D of target | >90% | >93% |
| Same-day discharge (day-case) | >90% | >95% |
| Unplanned readmission (30-day) | <2% | <1% |
Table 5.2 — Clinical outcome benchmarks and targets
5.4 The Patient Journey
A defining feature of the VisionCare model is a deliberately
engineered, friction-free patient journey that maximises both clinical
safety and experience while supporting efficient throughput:
- Referral & access — digital referral from optometrist/GP, or
direct self-referral for elective work, with rapid triage and
booking. - Assessment — comprehensive examination and advanced diagnostics
(OCT, biometry, fields) in a single visit where possible. - Decision & authorisation — shared decision-making,
transparent costing, and pre-authorisation handled by the revenue-cycle
team. - Procedure — standardised, high-throughput surgical lists in
dedicated ophthalmic theatres with structured peri-operative
care. - Recovery & discharge — protocol-driven same-day discharge for
the large majority of cases. - Follow-up & co-management — structured post-operative review,
with co-management feedback to the referring practitioner and recall for
recurring therapies.
This pathway is supported end-to-end by the integrated EMR, ensuring
continuity, traceability and the outcomes data that underpin both
quality improvement and scheme negotiations.
Confidential — this business plan is provided to prospective investors and lenders for evaluation purposes only and may not be reproduced or distributed without the written consent of VisionCare Specialist Eye Hospital (Pty) Ltd.